{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:30:59Z","timestamp":1790116259830,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.brachy.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T04:49:21Z","timestamp":1298609361000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective"],"prefix":"10.1016","volume":"10","author":[{"given":"Kara L.","family":"Leonard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolan L.","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Mignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Duker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2011.01.006_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. COMS Report No. 3","volume":"14","year":"1993","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.brachy.2011.01.006_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy: COMS Report No. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","article-title":"Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine-125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27","volume":"114","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archopht.124.2.226","article-title":"Quality of life after iodine-125 brachytherapy vs. enucleation for choroidal melanoma: 5-Year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma: V.\u00a0Twelve-year mortality rates and prognostic factors: COMS Report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brachy.2009.03.189","article-title":"125I episcleral plaque brachytherapy in the treatment of choroidal melanoma: A single-institution experience in Spain","volume":"8","author":"Correa","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2011.01.006_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brachy.2006.03.045","article-title":"Results of primary treatment of small or medium sized uveal melanoma with custom-made Nag iodine-125 eye plaque: The Ohio State University experience with 119 patients","volume":"5","author":"El-Ghamry","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2011.01.006_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2005.01.022","article-title":"Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma","volume":"63","author":"Jensen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.eye.6701361","article-title":"125I plaque brachytherapy for anterior uveal melanomas","volume":"18","author":"Lumbroso-Le Rouic","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.brachy.2011.01.006_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0360-3016(03)00324-9","article-title":"Custom-made \u201cNag\u201d eye plaques for 125I brachytherapy","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0360-3016(01)02723-7","article-title":"Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: Dose and dose rate effects","volume":"52","author":"Jones","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib12","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2356::AID-CNCR26>3.0.CO;2-V","article-title":"125I plaque therapy for uveal melanoma: Analysis of the impact of time and dose factors on local control","volume":"77","author":"Quivey","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2011.01.006_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0360-3016(93)90278-4","article-title":"Treatment of choroidal melanoma with I-125 plaque","volume":"26","author":"Fontanesi","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90277-3","article-title":"High intensity 125-iodine (125I) plaque treatment of uveal melanoma","volume":"26","author":"Quivey","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(92)31899-8","article-title":"Long-term results of iodine 125 irradiation of uveal melanoma","volume":"99","author":"Packer","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0360-3016(92)90017-C","article-title":"Episcleral plaque thermoradiotherapy in patients with choroidal melanoma","volume":"23","author":"Petrovich","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0161-6420(02)01174-0","article-title":"Late radiation failures after iodine 25 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy","volume":"109","author":"Char","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.125.8.1051","article-title":"High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas","volume":"125","author":"Finger","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ophtha.2008.12.027","article-title":"Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 Treated patients","volume":"116","author":"Finger","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0360-3016(02)03751-3","article-title":"Palladium-103 plaque radiation therapy for choroidal melanoma: An 11-year study","volume":"54","author":"Finger","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/bjo.84.9.1068","article-title":"Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy","volume":"84","author":"Finger","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archopht.1996.01100140557006","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma","volume":"114","author":"DePotter","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000421-199006000-00001","article-title":"Episcleral radioactive plaque therapy: Initial clinical experience with 56 patients","volume":"13","author":"Lean","year":"1990","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2011.01.006_bib24","first-page":"838","article-title":"Plaque radiotherapy for large posterior uveal melanomas (>8 mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2011.01.006_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00347-006-1451-3","article-title":"High dose (106)Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinic-pathologic study","volume":"104","author":"Heindl","year":"2007","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.brachy.2011.01.006_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","article-title":"Local tumor control after 106Ru brachytherapy of choroidal melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement","volume":"127","author":"Gunduz","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0420.1997.tb00241.x","article-title":"Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma, the Swedish experience","volume":"75","author":"Seregard","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.brachy.2011.01.006_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.70.11.844","article-title":"Results after beta-irradiation (106Ru\/106Rh) of choroidal melanomas: 20 Years\u2019 experience","volume":"70","author":"Lommatzsch","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2011.01.006_bib30","first-page":"82","article-title":"Long-term follow-up for Ru-106 brachytherapy in conservative treatment of uveal melanoma","volume":"24","author":"Lommatzsch","year":"1993","journal-title":"Arch Clin Exp Ophthalmol Surg"},{"key":"10.1016\/j.brachy.2011.01.006_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American brachytherapy society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib32","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1016\/j.ijrobp.2010.07.638","article-title":"Eye plaque brachytherapy for the treatment of uveal melanoma: The 2010 Tufts Medical Center experience","volume":"78S","author":"Leonard","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1118\/1.3523614","article-title":"Comparison of dose calculation methods for brachytherapy of ocular tumors","volume":"38","author":"Rivard","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1118\/1.598404","article-title":"Real-time B-mode ultrasound quality control test procedures: Report of AAPM Ultrasound Task Group No. 1","volume":"25","author":"Goodsitt","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1259\/bjr.71.845.9691890","article-title":"The clinical radiobiology of brachytherapy","volume":"71","author":"Dale","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2011.01.006_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.brachy.2009.07.007","article-title":"A comprehensive dosimetric comparison between 131Cs and 125I brachytherapy sources for COMS eye plaque implant","volume":"9","author":"Zhang","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2011.01.006_bib39","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1118\/1.2940604","article-title":"COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs","volume":"35","author":"Melhus","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2011.01.006_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brachy.2008.05.002","article-title":"The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs","volume":"7","author":"Rivard","year":"2008","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472111000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472111000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:05:40Z","timestamp":1761530740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472111000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1538472111000092"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2011.01.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2011.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}